ArticleCancers2019

Overcoming Intrinsic and Acquired Cetuximab Resistance in RAS Wild-Type Colorectal Cancer: An In Vitro Study on the Expression of HER Receptors and the Potential of Afatinib.

Ines De Pauw et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.